Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
26
27
28
29
30
31
1
3
4
5
6
7
8
9
10
11
13
14
15
16
18
19
21
22
23
24
25
26
27
28
29
30
1
2
3
4
5
6
2014 National Health Leadership Conference
2014-06-02    
All Day
WELCOME! This conference is the largest national gathering of health system decision-makers in Canada including trustees, chief executive officers, directors, managers, department heads and other [...]
EMR : Every Step Conference and Vendor Showcase
2014-06-12    
8:00 am - 6:00 pm
OntarioMD is pleased to invite you to join us for the EMR: Every Step Conference and Vendor Showcase, an interactive day to learn and participate in [...]
GOVERNMENT HEALTH IT Conference & Exhibition
Why Attend? As budgets tighten, workforces shrink, ICD-10 looms, more consumers enter the healthcare system and you still struggle with meaningful use — challenges remain [...]
MD Logic EHR User Conference 2014
2014-06-20    
All Day
Who Should Attend: Doctors, PA’s, NP’s, PT’s, Administrators,Managers, Clinical Staff, IT Staff What is the Focus of the Conference: Meaningful Use Stage II, ICD-10 and [...]
Events on 2014-06-02
Events on 2014-06-12
Events on 2014-06-17
Events on 2014-06-20
Articles

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

amyotrophic lateral scelrosis

Amyotrophic lateral sclerosis (ALS) Industry 2020 Rapidly Growing with High Revenue

Amyotrophic lateral sclerosis (ALS) belongs to a group of neurological disease. Otherwise called motor neuron diseases, they influence the engine elements of voluntary muscles in the body. Factors, for example, an expansion in the occurrence rate of ALS, grow in the awareness about the ailment among patients, and ascend in the geriatric populace is relied upon to help the development of the amyotrophic lateral sclerosis market. Other factors including the tendency towards the stationary way of life are driving the market development and expanding the danger of getting attacked by ALS.

Furthermore, the expanding geriatric populace substantiates market development, making interest in symptomatic and focused on treatment alternatives. However, the staggering expense of the treatment of ALS may impede market development over the figure time frame.

The Amyotrophic lateral sclerosis market is growing at 7.89 % CAGR and is expected to reach the valuation of USD 841.6 million by the year 2023.

Major players

Mylan N.V. (U.S.), Covis Pharma (Switzerland), Ionis Pharmaceutical (U.S.), ITF Pharma (U.S.), Ascend Pharmaceuticals LLC (U.S.), Apotex Inc. (Canada), Sun Pharmaceutical (India), Mitsubishi Tanabe Pharma America (U.S.), Biogen (U.S.), Sanofi (France), among others are some of the major players in the Global amyotrophic lateral sclerosis market.

The Global amyotrophic lateral sclerosis market has been classified on the basis of its treatment, type, end-user, and regional demand. Based on its type, the market is classified into familial ALS and sporadic. Based on its treatment, the market has been segmented into physical therapy, speech therapy, medication, respiratory therapy, and others. By its end-user, the ALS market has been segmented into research & academic institutes, specialty centers, hospitals, and others.

Source inforgrowth.com/report/1850367/amyotrophic-lateral-sclerosis-market

About InForGrowth

At InForGrowth, Understand Research requirements and help a client in taking informed business critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable and trusted publishing partners, we are paving way for a more simplified and relevant research.